Required BE studies for sevelamer for EU [Regulatives / Guidelines]

posted by Marcel – 2011-04-15 12:10 (5553 d 03:50 ago) – Posting: # 6903
Views: 4,809

❝ My question is, whether EMEA will accepts the In-vitro phosphate binding studies for generic submission like US or need to do the pharmacodynamic studies for this molecule.


We are working on this same assumption, however some people internally are voicing concerns that some EU member states may require some type of clinical trial. However, this is pure speculation based on anonymous rumors. It doesn't appear to have any scientific merit, as far as I can tell. Should I hear anything else, I'll let you know.

Marcel

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
308 visitors (0 registered, 308 guests [including 13 identified bots]).
Forum time: 16:00 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5